|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Insurance | |||||
| Insurance revenue | |||||
| Insurance service expenses | |||||
| Net insurance result | |||||
| Cost of reinsurance | |||||
| Recoveries of insurance service expenses | |||||
| Net reinsurance result | |||||
| Insurance service result | |||||
| Other insurance operating expenses | |||||
| Net finance expense from insurance contracts | |||||
| Net finance income from reinsurance contract assets held | |||||
| Total | |||||
| Investment income | |||||
| Interest and dividends | |||||
| Share of profit of associates | |||||
| Net gains on investments | |||||
| Total | |||||
| Other revenue and expenses | |||||
| Non-insurance revenue | |||||
| Non-insurance expenses | |||||
| Gain on sale and consolidation of insurance subsidiaries | |||||
| Commissions, net | |||||
| Interest expense | |||||
| Expenses | |||||
| Corporate and other expenses | |||||
| Total | |||||
| Earnings before income taxes | |||||
| Provision for income taxes | |||||
| Net earnings | |||||
| Net earnings per share (in dollars per share) | |||||
| Net earnings per diluted share (in dollars per share) | |||||
| Cash dividends paid per share (in dollars per share) | |||||
| Shares outstanding (000) (weighted average) (in shares) | |||||
| Attributable to: | |||||
| Shareholders of Fairfax | |||||
| Non-controlling interests | |||||
Loading...